Zobrazeno 1 - 10
of 14
pro vyhledávání: '"K. Mitchinson"'
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 133-136 (2015)
Pegylated liposomal doxorubicin (PLD) has become the preferred alternative for ovarian cancer patients who have failed platinumbased therapy, but side effects, such as palmar-plantar erythrodysesthesia (PPE), may lead to sub-optimal drug exposure and
Externí odkaz:
https://doaj.org/article/58ef44fbc57d406288a21aaf4642f7b8
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 137-140 (2015)
La doxorubicine liposomale pégylée (DLP) est devenue l’option de rechange la plus courante chez les patientes atteintes d’un cancer de l’ovaire chez qui la thérapie à base de platine a échoué. Dans certains cas, les effets secondaires com
Externí odkaz:
https://doaj.org/article/82159db5292e479e97cc3804da816152
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 137-140 (2007)
La doxorubicine liposomale pégylée (DLP) est devenue l’option de rechange la plus courante chez les patientes atteintes d’un cancer de l’ovaire chez qui la thérapie à base de platine a échoué. Dans certains cas, les effets secondaires com
Externí odkaz:
https://doaj.org/article/2e991bed9abb4f099164290be65c71bc
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 133-136 (2007)
Pegylated liposomal doxorubicin (PLD) has become the preferred alternative for ovarian cancer patients who have failed platinumbased therapy, but side effects, such as palmar-plantar erythrodysesthesia (PPE), may lead to sub-optimal drug exposure and
Externí odkaz:
https://doaj.org/article/20fa2f3c90204c99b74b1496819ffcc8
Autor:
K Mitchinson
Pioneer battalions, created as an expedient in 1914, were a new concept in the British Army. Intended to provide the Royal Engineers, with skilled labour and to relieve the infantry from some of its non-combatant duties, Pioneers became the work hors
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 137-140 (2007)
La doxorubicine liposomale pegylee (DLP) est devenue l’option de rechange la plus courante chez les patientes atteintes d’un cancer de l’ovaire chez qui la therapie a base de platine a echoue. Dans certains cas, les effets secondaires comme l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97d59e04f375c9c262aed97d6a0056c
http://www.canadianoncologynursingjournal.com/index.php/conj/article/view/263/266
http://www.canadianoncologynursingjournal.com/index.php/conj/article/view/263/266
Publikováno v:
Canadian Oncology Nursing Journal, Vol 17, Iss 3, Pp 133-136 (2007)
Pegylated liposomal doxorubicin (PLD) has become the preferred alternative for ovarian cancer patients who have failed platinum-based therapy, but side effects, such as palmar-plantar erythrodysesthesia (PPE), may lead to sub-optimal drug exposure an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a928e32280c59428b3abeb3607ce1b1
https://doi.org/10.5737/1181912x173133136
https://doi.org/10.5737/1181912x173133136
Publikováno v:
Current Oncology
Volume 15
Issue 1
Pages 200-41
Current Oncology; Volume 15; Issue 1; Pages: 36-41
Volume 15
Issue 1
Pages 200-41
Current Oncology; Volume 15; Issue 1; Pages: 36-41
The goal of the 1-year observational, multicentre, open-label study reported here was to identify factors influencing adherence to high-dose interferon alfa-2b adjuvant therapy in patients at high risk of recurrence following surgical excision of mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb61fe9938f72e9bf13d4e0f80fd7c59
Publikováno v:
Melanoma Research. 16:S38-S39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33e46528b055384fa00949b7adff346e
https://doi.org/10.1097/00008390-200609001-00067
https://doi.org/10.1097/00008390-200609001-00067
Autor:
K. Mitchinson, M. Foster, V. Lebel, M. Gill, N. Grenier, Jean-François Pouliot, S. Lewis, A. Rodgers, K. Sebborn, T. Mullen
Publikováno v:
Journal of Clinical Oncology. 23:8198-8198
8198 Background: A significant long-term survival with PLD compared to topotecan was recently reported in a phase III randomized study of women with REOC (Gyn. Oncol. 2004). PLD is known to be rela...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c372c910283a39c745e1d827b5f84416
https://doi.org/10.1200/jco.2005.23.16_suppl.8198
https://doi.org/10.1200/jco.2005.23.16_suppl.8198